As shown in the UALCAN dataset, the SLC16A3 protein was highly expressed in BRCA, ccRCC, COAD, GBM, HCC, HNSC, LUAD, PAAD, and UCEC, but was lower in gastric cancer and did not significantly differ in ovarian cancer (Fig. 3A and K). Here, SLC16A3 is linked to invasive breast carcinoma.